Akebia Therapeutics, Inc. (AKBA)
1.335
-0.04
(-3.26%)
USD |
NASDAQ |
Jan 15, 16:00
1.35
+0.02
(+1.12%)
After-Hours: 19:01
Akebia Therapeutics SG&A Expense (TTM): 112.54M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.91B |
| Plus Therapeutics, Inc. | 11.09M |
| Ironwood Pharmaceuticals, Inc. | 96.29M |
| Pyxis Oncology, Inc. | 22.04M |
| Theravance Biopharma, Inc. | 75.94M |